FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dimosthenis Skarlos

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

Greece

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
George Fountzilas; Anna Kalogera-Fountzila; Georgia Karayannopoulou; Konstantinos Markou; Despina Misailidou; Angelos Nikolaou; L Resiga; Epaminondas Samantas; Dimosthenis Skarlos; Thomas Zaramboukas; Helen Athanassiou; Mattheos Bobos; E Ciuleanu; D Dionysopoulos; A G Eleftheraki; tudor ciuleanu
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Dimitrios Pectasides; Dimosthenis Skarlos; Ioannis Varthalitis; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Bournakis; Athanassios Meletios Dimopoulos; Helen Fountzilas; Haralabos P Kalofonos; Konstantine T Kalogeras; Ippokratis Korantzis; Paris Kosmidis; Vassiliki Kotoula; Angelos Koutras; Pavlos Papakostas; George Papaxoinis; George Fountzilas
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.
Ioanna Saratsiotou; Dimosthenis Skarlos; Charalampos Bakogiannis; Maria Kordoni; Paris A Kosmidis; Eleftheria Livadarou; Evangelia Razis
Treatment adherence of cancer patients to orally administered chemotherapy: insights from a Greek study using a self-reported questionnaire.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dimosthenis Skarlos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: George Fountzilas; Anna Kalogera-Fountzila; Georgia Karayannopoulou; Konstantinos Markou; Despina Misailidou; Angelos Nikolaou; L Resiga; Epaminondas Samantas; Dimosthenis Skarlos; Thomas Zaramboukas; Helen Athanassiou; Mattheos Bobos; E Ciuleanu; D Dionysopoulos; A G Eleftheraki; tudor ciuleanu
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):427-35.
2012: Dimitrios Pectasides; Dimosthenis Skarlos; Ioannis Varthalitis; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Bournakis; Athanassios Meletios Dimopoulos; Helen Fountzilas; Haralabos P Kalofonos; Konstantine T Kalogeras; Ippokratis Korantzis; Paris Kosmidis; Vassiliki Kotoula; Angelos Koutras; Pavlos Papakostas; George Papaxoinis; George Fountzilas
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.
Oncology reports 2012;27(1):216-24.
2011: Ioanna Saratsiotou; Dimosthenis Skarlos; Charalampos Bakogiannis; Maria Kordoni; Paris A Kosmidis; Eleftheria Livadarou; Evangelia Razis
Treatment adherence of cancer patients to orally administered chemotherapy: insights from a Greek study using a self-reported questionnaire.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2011;17(4):304-11.
2011: Evangelia Razis; G Rigakos; Dimosthenis Skarlos; Gerasimos Aravantinos; Dimitrios Bafaloukos; Mattheos Bobos; Ioannis Efstratiou; A G Eleftheraki; Haralabos P Kalofonos; K T Kalogeras; Ioannis Kostopoulos; Vassiliki Kotoula; Pavlos Papakostas; Kitty Pavlakis; Dimitrios Pectasides; K Petraki; George Fountzilas
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
Breast cancer research and treatment 2011;128(2):447-56.
2011: Paris A Kosmidis; George Fountzilas; A G Eleftheraki; Haralabos P Kalofonos; G Pentheroudakis; Dimosthenis Skarlos; Meletios A Dimopoulos; Dimitrios Bafaloukos; D Pectasides; Epaminondas Samantas; J Boukovinas; S Lambaki; N Katirtzoglou; C Bakogiannis; K N Syrigos
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):827-34.
2010: Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimosthenis Skarlos; George Papaxoinis; Mattheos Bobos; Haralabos P Kalofonos; Kalliopi Petraki; Kitty Pavlakis; Dimitrios Bafaloukos; George Fountzilas
Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.
Clinical breast cancer 2010;10(3):230-7.
2010: Michalakis Averkiou; Marios Lampaskis; Konstantina Kyriakopoulou; Dimosthenis Skarlos; Georgios Klouvas; Costas Strouthos; Edward Leen
Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy.
Ultrasound in medicine & biology 2010;36(1):68-77.
2009: George Pentheroudakis; Konstantine T Kalogeras; Ralph M Wirtz; Irene Grimani; George Zografos; Helen Gogas; Udo Stropp; Dimitrios Pectasides; Dimosthenis Skarlos; Guido Hennig; Epaminondas Samantas; Dimitrios Bafaloukos; Pavlos Papakostas; Haralabos P Kalofonos; Nicholas Pavlidis; George Fountzilas
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast cancer research and treatment 2009;116(1):131-43.
2009: George Fountzilas; Urania Dafni; Meletios A Dimopoulos; A Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Epaminondas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F Matsiakou; Gerasimos Aravantinos; Christos Papadimitriou; Maria Karina; Christos Christodoulou; Paris A Kosmidis; Haralabos P Kalofonos
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Dimitrios Pectasides; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Aristidis Polyzos; Dimosthenis Tsoutsos; Haralambos Kalofonos; George Fountzilas; Petros Panagiotou; George Kokkalis; Othon Papadopoulos; Ourania Castana; Stefanos Papadopoulos; Elias Stavrinidis; Georgia Vourli; John Ioannovich; Helen Gogas
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):939-44.
2009: George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Dimosthenis Skarlos
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.
Journal of oncology 2009;2009():305908.
2008: David Cameron; Michelle Casey; Michael Press; Deborah Lindquist; Tadeusz Pienkowski; C Gilles Romieu; Stephen Chan; Agnieszka Jagiello-Gruszfeld; Bella Kaufman; John Crown; Arlene Chan; Mario Campone; Patrice Viens; Neville Davidson; Vera Gorbounova; Johannes Isaac Raats; Dimosthenis Skarlos; Beth Newstat; Debasish Roychowdhury; Paolo Paoletti; Cristina Oliva; Stephen Rubin; Steven Stein; Charles E Geyer
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
Breast cancer research and treatment 2008;112(3):533-43.
2008: George Fountzilas; Urania Dafni; Helen Gogas; Helena Linardou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Dimitrios Bafaloukos; George P Stathopoulos; Maria Karina; Christos Papadimitriou; Dimosthenis Skarlos; N Pisanidis; Pavlos Papakostas; Christos Markopoulos; E Tzorakoeleftherakis; K Dimitrakakis; P Makrantonakis; N Xiros; A Polichronis; I Varthalitis; Charisios Karanikiotis; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):853-60.
2008: Irene Konstantopoulou; Theodoros Rampias; Angela Ladopoulou; George Koutsodontis; Sophia Armaou; Theodore Anagnostopoulos; George Nikolopoulos; Smaragda Kamakari; George Nounesis; Antonis Stylianakis; Charisios Karanikiotis; Evangelia Razis; Helen Gogas; Antonios Keramopoulos; Vasiliki Gaki; Christos Markopoulos; Dimosthenis Skarlos; Nikos Pandis; Thalia Bei; Iordanis I Arzimanoglou; George Fountzilas; Drakoulis Yannoukakos
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2008;107(3):431-41.
2008: Paris A Kosmidis; Haralabos P Kalofonos; Christos Christodoulou; Konstantinos Syrigos; Thomas Makatsoris; Dimosthenis Skarlos; C Bakogiannis; Costas Nicolaides; Dimitrios Bafaloukos; Aristotelis Bamias; Epaminondas Samantas; Nikolaos Xiros; Ioannis Boukovinas; George Fountzilas; Meletios A Dimopoulos
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):115-22.
2007: Paris A Kosmidis; George Fountzilas; S Baka; Epaminondas Samantas; Athanassios Meletios Dimopoulos; Helen Gogas; Dimosthenis Skarlos; P Papacostas; J Boukovinas; Ch Bakogiannis; P Pantelakos; H Athanasiou; Despina Misailidou; Pericles G Tsekeris; Nicholas Pavlidis
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer research 2007;27(6C):4391-5.
2007: Savvas Papadopoulos; George Kouvatseas; Dimosthenis Skarlos; Nikolaos Malamos; Eleftheria Delliou; Ioanna Saratsiotou; Alexandros Ardavanis; Dimitrios Mavroudis; Eva Skarpidi; Petroula Arapantoni; Irini Karyda; Frideriki Patakioyta; Gerasimos Aravantinos; Evangelia Razis; George Fountzilas; Paris A Kosmidis
Comparison of HER2 detection methods between central and regional laboratories in Greece.
Clinical breast cancer 2007;7(10):784-90.
2007: George P Stathopoulos; Nikolaos Malamos; Gerasimos Aravantinos; Sotiris K Rigatos; Ch Christodoulou; John G Stathopoulos; Dimosthenis Skarlos
Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
Cancer chemotherapy and pharmacology 2007;60(1):123-8.
2007: Joseph Sgouros; Eleni Galani; Efstathios S Gonos; paraskevi moutsatsou; Maria Belechri; Dimosthenis Skarlos; Amalia Dionyssiou-Asteriou
Correlation of nm23-H1 gene expression with clinical outcome in patients with advanced breast cancer.
In vivo (Athens, Greece) 2007;21(3):519-22.
2007: Dimitrios Pectasides; Christos Valavanis; Maria Nikolaou; Gerasimos Aravantinos; I Lekka; Dimosthenis Skarlos; Charalambos Kalofonos; George Fountzilas; Vassiliki Kostopoulou; A Zizi; Theofanis Economopoulos; P Arapantoni-Datioti
Molecular markers in extragonadal germ cell tumours: a matched case-control study.
Histopathology 2007;50(3):394-6.
2006: Charles E Geyer; John Forster; Deborah Lindquist; Stephen Chan; C Gilles Romieu; Tadeusz Pienkowski; Agnieszka Jagiello-Gruszfeld; John Crown; Arlene Chan; Bella Kaufman; Dimosthenis Skarlos; Mario Campone; Neville Davidson; Mark Berger; Cristina Oliva; Stephen D Rubin; Steven Stein; David Cameron
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
The New England journal of medicine 2006;355(26):2733-43.
2006: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Helen Efstathiou; Dimitrios Farmakis; Dimosthenis Skarlos; Nicholas Pavlidis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
2006: George Pentheroudakis; George Fountzilas; Dimitrios Bafaloukos; Vasiliki Koutsoukou; Dimitrios Pectasides; Dimosthenis Skarlos; Epaminondas Samantas; Haralabos P Kalofonos; Helen Gogas; Nicholas Pavlidis
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Breast cancer research and treatment 2006;97(3):237-44.
2006: George P Stathopoulos; Ch Christodoulou; John G Stathopoulos; Dimosthenis Skarlos; Sotiris K Rigatos; THEODORE GIANNAKAKIS; Ourania Armenaki; Dimosthenis Antoniou; Athanasios Athanasiadis; Pantelis Giamboudakis; IOANNIS DIMITROULIS; Niki Georgatou; Kostas Katis
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
Cancer chemotherapy and pharmacology 2006;57(6):796-800.
2006: Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoulos; Vassiliki Malamou-Mitsi; Chrisoula D Scopa; Sophia Markaki; Evangelia Karagianni; Vassiliki Kyriakou; Anastasia Margariti; Elisavet Kyrkou; Kitty Pavlakis; Thomas Zaramboukas; Anna Skordalaki; Antonia Bourli; Christos Markopoulos; Dimitrios Pectasides; Meletios A Dimopoulos; Dimosthenis Skarlos; George Fountzilas
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Breast cancer research and treatment 2006;96(3):251-61.
2006: Aristotelis Bamias; Lia A Moulopoulos; Angelos Koutras; Gerasimos Aravantinos; George Fountzilas; Dimitrios Pectasides; Efstathios Kastritis; Dimitra Gika; Dimosthenis Skarlos; Helena Linardou; Haralabos P Kalofonos; Meletios A Dimopoulos
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer 2006;106(2):297-303.
2006: George Fountzilas; Dimitrios Pectasides; Christos Christodoulou; Eleni Timotheadou; Theofanis Economopoulos; Pavlos Papakostas; Christos Papadimitriou; Helen Gogas; Ioannis Efstratiou; Dimosthenis Skarlos
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer.
Medical oncology (Northwood, London, England) 2006;23(4):479-88.
2006: Pavlos Papakostas; Dimitrios Tsavdaridis; Paris Kosmidis; Haralabos P Kalofonos; Athanassios Sakantamis; Dimitrios Janinis; Dimosthenis Skarlos; Dimitrios Bafaloukos; Aristotelis Bamias; Nikolaos Xiros; George Fountzilas
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2006;9(1):26-31.
2005: George Fountzilas; Dimosthenis Skarlos; Urania Dafni; Helen Gogas; Evangelos Briasoulis; Dimitrios Pectasides; Christos Papadimitriou; Christos Markopoulos; A Polychronis; Haralabos P Kalofonos; V Siafaka; Paris A Kosmidis; Eleni Timotheadou; Dimitrios Tsavdaridis; Dimitrios Bafaloukos; Pavlos Papakostas; Evangelia Razis; P Makrantonakis; Gerasimos Aravantinos; Christos Christodoulou; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
2005: Evangelos Briasoulis; Epaminondas Samantas; Haralambos Kalofonos; Dimosthenis Skarlos; Thomas Makatsoris; Christos Christodoulou; George Fountzilas; Aristotelis Bamias; M A Dimopoulos; Paris A Kosmidis; Nicholas Pavlidis
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
2005: Georgios Fotios Samelis; Haralambos Kalofonos; Adamos Adamou; Paris Kosmides; Dimosthenis Skarlos; Gerasimos Aravantinos; Christos Kiamouris; Oneynadum Adimchi; George Fountzilas; Athanassios Meletios Dimopoulos
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2005;66(2):382-5.
2005: Eleni Galani; Dimosthenis Skarlos; Joseph Sgouros; M Litos; Efstathios S Gonos; Amalia Dionyssiou-Asteriou
Correlation of MDR 1 expression and CA 125 in ovarian cancer.
In vivo (Athens, Greece) 2005;19(4):797-800.
2005: George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Skarlos; Haralabos P Kalofonos; Christos Papadimitriou; Dimitrios Bafaloukos; Stefanos Lambropoulos; Savvas Papadopoulos; Helen P Kourea; Christos Markopoulos; Helena Linardou; Dimitrios Mavroudis; Evangelos Briasoulis; Nicholas Pavlidis; Evangelia Razis; Paris A Kosmidis; Helen Gogas
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Haralabos P Kalofonos; Gerasimos Aravantinos; Paris A Kosmidis; Pavlos Papakostas; Theofanis Economopoulos; Meletios A Dimopoulos; Dimosthenis Skarlos; Aristotelis Bamias; Dimitrios Pectasides; S Chalkidou; Maria Karina; Angelos Koutras; Epaminondas Samantas; Christos Bacoyiannis; Georgios Fotios Samelis; George Basdanis; Fotis Kalfarentzos; George Fountzilas
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Nikolaos Xiros; P Papacostas; Theofanis Economopoulos; Georgios Fotios Samelis; Eleni Efstathiou; Efstathios Kastritis; Haralambos Kalofonos; Adimchi Onyenadum; Dimosthenis Skarlos; Aristotelis Bamias; Helen Gogas; Dimitrios Bafaloukos; Epaminondas Samantas; Paris A Kosmidis
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):773-9.
2005: Evangelia Razis; Dimosthenis Skarlos; Evangelos Briasoulis; Meletios A Dimopoulos; George Fountzilas; S Lambropoulos; Sotiris K Rigatos; P Kopterides; H Efstathiou; Eleftheria Tzamakou; Chris N Bakoyannis; Dimitrios Pectasides; Thomas Makatsoris; G Varthalitis; Savvas Papadopoulos; Paris A Kosmidis
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Anti-cancer drugs 2005;16(2):191-8.
2005: George Fountzilas; Christos Tolis; Anna Kalogera-Fountzila; Despina Misailidou; Pericles G Tsekeris; Maria Karina; Angelos Nikolaou; Epaminondas Samantas; Thomas Makatsoris; Eleni Athanassiou; Dimosthenis Skarlos; Aristotelis Bamias; Nikolaos Zamboglou; Theofanis Economopoulos; Sophia Karanastassi; Nicholas Pavlidis; John Daniilidis
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.
Medical oncology (Northwood, London, England) 2005;22(3):269-79.
2005: Christos Christodoulou; Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Aristotelis Bamias; Maria Carina; George Klouvas; Dimosthenis Skarlos
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Journal of neuro-oncology 2005;71(1):61-5.
2005: Eleni Efstathiou; George Bozas; Athanasios Kostakopoulos; Efstathios Kastritis; Charalambos Deliveliotis; Nikolaos Antoniou; Dimosthenis Skarlos; Christos Papadimitriou; Meletios A Dimopoulos; Aristotelis Bamias
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Urology 2005;65(1):126-30.
2004: Meletios A Dimopoulos; Christos Papadimitriou; George Hamilos; Eleni Efstathiou; George Vlahos; Alexandros Rodolakis; Gerasimos Aravantinos; Haralambos Kalofonos; Charalambos Kouroussis; Dimitra Gika; Dimosthenis Skarlos; Aristotelis Bamias
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Gynecologic oncology 2004;95(3):695-700.
2004: Dimitrios Bafaloukos; Christos Papadimitriou; Helena Linardou; Gerasimos Aravantinos; Pavlos Papakostas; Dimosthenis Skarlos; Paris A Kosmidis; George Fountzilas; Helen Gogas; Charalambos Kalofonos; Athanassios Meletios Dimopoulos
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
British journal of cancer 2004;91(9):1639-44.
2004: George Fountzilas; Haralabos P Kalofonos; Urania Dafni; Christos Papadimitriou; Dimitrios Bafaloukos; Pavlos Papakostas; Anna Kalogera-Fountzila; Helen Gogas; Gerasimos Aravantinos; Lia A Moulopoulos; Theofanis Economopoulos; Dimitrios Pectasides; N Maniadakis; V Siafaka; Evangelos Briasoulis; Christos Christodoulou; Dimitrios Tsavdaridis; P Makrantonakis; Evangelia Razis; Paris A Kosmidis; Dimosthenis Skarlos; Meletios A Dimopoulos
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Sanjiv S Agarwala; John M Kirkwood; Martin Gore; Brigitte Dreno; Nicholas Thatcher; Beate Czarnetski; Michael Atkins; Antonio C Buzaid; Dimosthenis Skarlos; Elaine M Rankin
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2101-7.
2004: Helen Gogas; Dimitrios Bafaloukos; John Ioannovich; Dimosthenis Skarlos; Aristidis Polyzos; George Fountzilas; Haralabos P Kalofonos; Gerasimos Aravantinos; Dimosthenis A Tsoutsos; Petros Panagiotou; Konstantina Frangia; Theodora Petrakopoulou; Dimitrios Pectasides
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
Anticancer research 2004;24(3b):1947-52.
2004: Dimitrios Pectasides; Melina Pectasides; Dimitrios Farmakis; Gerasimos Aravantinos; Maria Nikolaou; Maria Koumpou; Asimina Gaglia; Vassiliki Kostopoulou; Nicolas Mylonakis; Dimosthenis Skarlos
Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):493-7.
2004: George Fountzilas; George P Stathopoulos; George Kouvatseas; A Polychronis; George Klouvas; Epaminondas Samantas; Nikolaos Zamboglou; K Kyriakou; Adamos Adamou; D Pectasidis; Th Ekonomopoulos; Haralabos P Kalofonos; Dimitrios Bafaloukos; Vassilis Georgoulias; Evangelia Razis; Dimitrios Koukouras; V Zombolas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: George Fountzilas; Christos Christodoulou; Dimitrios Tsavdaridis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Evangelia Razis; Haralabos P Kalofonos; Pavlos Papakostas; Maria Karina; Helen Gogas; Dimosthenis Skarlos
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Cancer investigation 2004;22(5):655-62.
2003: Dimitrios Pectasides; Dimosthenis Skarlos; Athanassios Meletios Dimopoulos; Dimitrios Farmakis; Melina Pectasides; George Fountzilas; Gerasimos Aravantinos
Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Anticancer research 2003;23(5b):4239-44.
2003: George Fountzilas; Evangelia Razis; Dimitrios Tsavdaridis; Maria Karina; Stefanos Labropoulos; Christos Christodoulou; Dimitrios Mavroudis; Helen Gogas; Vassilis Georgoulias; Dimosthenis Skarlos
Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.
Clinical breast cancer 2003;4(2):120-5.
2003: Georgios Fotios Samelis; Dimosthenis Skarlos; D Bafaloukos; Paris A Kosmidis; A Anagnostopoulos; Gerasimos Aravantinos; Meletios A Dimopoulos
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2003;61(6):1211-5.
2003: Haralabos P Kalofonos; Dimitrios Kardamakis; Aristotelis Bamias; Dimosthenis Skarlos; Pavlos Papakostas; Dimitrios Bafaloukos; Athanasios Sakantamis; Nicolas Pavlidis; George Fountzilas
Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
Anticancer research 2003;23(2C):1687-91.
2003: Haralabos P Kalofonos; Dimosthenis Skarlos; Dimitrios Bafaloukos; Pavlos Papakostas; Aristotelis Bamias; Jim Janinis; Eleni Timotheadou; George Kouvatseas; M Stavropoulos; T Economopulos; George Fountzilas
A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma.
Cancer investigation 2003;21(6):855-62.
2002: Angela Ladopoulou; Christos Kroupis; Irene Konstantopoulou; L Ioannidou-Mouzaka; Andrew C Schofield; Alexandros Pantazidis; Sophia Armaou; I Tsiagas; Evi S Lianidou; Eleni Efstathiou; Christina Tsionou; Christos Panopoulos; Markos Mihalatos; Georgios Nasioulas; Dimosthenis Skarlos; Neva E Haites; George Fountzilas; Nikos Pandis; Drakoulis Yannoukakos
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Cancer letters 2002;185(1):61-70.
2002: Paris A Kosmidis; Nicolas Mylonakis; Costas Nicolaides; Charalabos Kalophonos; Epaminondas Samantas; John Boukovinas; George Fountzilas; Dimosthenis Skarlos; Theofanis Economopoulos; Dimitrios Tsavdaridis; Pavlos Papakostas; Christos Bacoyiannis; Meletios A Dimopoulos
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3578-85.
2002: Eleni Galani; Joseph Sgouros; Chariklia Petropoulou; Jim Janinis; Gerasimos Aravantinos; Dionysia Dionysiou-Asteriou; Dimosthenis Skarlos; Efstathios S Gonos
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Anticancer research 2002;22(4):2275-80.
2002: Meletios A Dimopoulos; Christos A Papadimitriou; Kyrillos Sarris; Gerasimos Aravantinos; Charalambos Kalofonos; Dimitra Gika; Georgios M Gourgoulis; Eleni Efstathiou; Dimosthenis Skarlos; Dimitrios Bafaloukos
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
Gynecologic oncology 2002;85(3):476-82.
2002: Dimitrios Bafaloukos; Helen Gogas; V Georgoulias; Evangelos Briassoulis; George Fountzilas; Epaminondas Samantas; Charalambos Kalofonos; Dimosthenis Skarlos; Athanasios Karabelis; Paris A Kosmidis
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):420-5.
2002: Christos Bacoyiannis; Meletios A Dimopoulos; Haralabos P Kalofonos; Costas Nicolaides; Gerasimos Aravantinos; Dimitrios Bafaloukos; Georgios Fotios Samelis; Adimchi Onyenadum; Christos Kiamouris; Dimosthenis Skarlos; Nicholas Pavlidis; A Triantafillidis; Paris A Kosmidis
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2001: George Fountzilas; Dimitrios Tsavdaridis; Anna Kalogera-Fountzila; C H Christodoulou; Eleni Timotheadou; C H Kalofonos; Paris A Kosmidis; Adamos Adamou; Pavlos Papakostas; Helen Gogas; George P Stathopoulos; Evangelia Razis; Dimitrios Bafaloukos; Dimosthenis Skarlos
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1545-51.
2001: Dimitrios Pectasides; M A Dimopoulos; Gerasimos or Gerassimos Aravantinos; H P Kalophonos; P Papacostas; E Briasoulis; E Cogas; C Papadimitriou; Dimosthenis Skarlos; Paris A Kosmidis; George Fountzilas
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
Anticancer research 2001;21(5):3575-80.
2001: Dimitrios Pectasides; Haralabos P Kalofonos; Epaminondas Samantas; Costas Nicolaides; P Papacostas; Adimchi Onyenadum; A Visvikis; Dimosthenis Skarlos; George Fountzilas
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Anticancer research 2001;21(4B):3005-10.
2001: George Fountzilas; Christos Papadimitriou; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Lia A Moulopoulos; Evangelia Razis; Haralabos P Kalofonos; Gerasimos Aravantinos; Evangelos Briassoulis; Pavlos Papakostas; K Abela; E Gogas; Paris A Kosmidis; Nicholas Pavlidis; Meletios A Dimopoulos
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: George Fountzilas; Christos Papadimitriou; Gerasimos Aravantinos; Costas Nicolaides; George P Stathopoulos; Dimitrios Bafaloukos; Haralambos Kalofonos; T Ekonomopoulos; Dimosthenis Skarlos; Nicholas Pavlidis; Athanassios Meletios Dimopoulos
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
2001: Georgia Agiostratidou; I Sgouros; Eleni Galani; A Voulgari; Niki Chondrogianni; Epaminondas Samantas; Meletios A Dimopoulos; Dimosthenis Skarlos; Efstathios S Gonos
Correlation of in vitro cytotoxicity and clinical response to chemotherapy in ovarian and breast cancer patients.
Anticancer research 2001;21(1A):455-9.
2000: Epaminondas Samantas; Haralambos Kalofonos; Helena Linardou; Costas Nicolaides; Nicolas Mylonakis; George Fountzilas; Paris A Kosmidis; Dimosthenis Skarlos
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1395-7.
2000: Irene Konstantopoulou; Christos Kroupis; Angela Ladopoulou; Alexandros Pantazidis; D Boumba; Evi S Lianidou; Michael B Petersen; L Florentin; Efstratios Chiotellis; George Nounesis; Eleni Efstathiou; Dimosthenis Skarlos; Christina Tsionou; George Fountzilas; Drakoulis Yannoukakos
BRCA1 mutation analysis in breast/ovarian cancer families from Greece.
Human mutation 2000;16(3):272-3.
2000: Evangelos Briasoulis; Haralambos Kalofonos; Dimitrios Bafaloukos; Epaminondas Samantas; George Fountzilas; Nikolaos Xiros; Dimosthenis Skarlos; C Christodoulou; Paris A Kosmidis; Nicholas Pavlidis
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
2000: Nicolas Tsavaris; Dimosthenis Skarlos; Christos Bacoyiannis; Gerasimos Aravantinos; Christos Kosmas; George Retalis; Christos Panopoulos; Maria Vadiaka; Antonios Dimitrakopoulos; K Kostantinidis; Dionisios Mitropoulos; Dimitrios A Bougas; Dimitrios Pantazopoulos; Paris A Kosmidis
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(8):685-90.
2000: Paris A Kosmidis; Nicolas Mylonakis; Dimosthenis Skarlos; Epaminondas Samantas; Meletios A Dimopoulos; C Papadimitriou; Charalabos Kalophonos; Nicholas Pavlidis; C Nikolaidis; C Papaconstantinou; George Fountzilas
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
2000: Jim Janinis; Eleni Efstathiou; Christos Panopoulos; Epaminondas Samantas; Gerasimos Aravantinos; Christos Christodoulou; Dimosthenis Skarlos
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status.
Medical oncology (Northwood, London, England) 2000;17(2):106-10.
2000: Dimitrios Pectasides; Theofanis Economopoulos; George Kouvatseas; A Antoniou; Z Zoumbos; Gerasimos Aravantinos; Costas Tsatalas; A Halikia; Costas Nikolaides; Christos Kiamouris; E Pappa; Nicholas Pavlidis; Dimosthenis Skarlos; George Fountzilas; Meletios A Dimopoulos
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
2000: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; Spiros Papavramidis; A Bousoulegas; George Basdanis; Eleftherios Giannoulis; J Dokmetzioglou; C Katsohis; E Nenopoulou; N Karvounis; Evangelos Briassoulis; Gerasimos Aravantinos; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
2000: Jim Janinis; Pavlos Papakostas; Georgios Fotios Samelis; Dimosthenis Skarlos; P Papagianopoulos; George Fountzilas
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):163-7.
2000: Paris A Kosmidis; Nicolas Mylonakis; Athanassios Meletios Dimopoulos; Nicholas Pavlidis; George Fountzilas; Epaminondas Samantas; K Dimitriadis; Charalabos Kalophonos; Dimitrios Tsavdaridis; Dimosthenis Skarlos
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Seminars in oncology 2000;27(1 Suppl 2):3-8.
2000: Jim Janinis; THEODORE GIANNAKAKIS; A Athanasiades; George Fountzilas; Dimitrios Bafaloukos; Paris A Kosmidis; K Nikolaides; Nicholas Pavlidis; Dimosthenis Skarlos
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
Tumori 2000;86(1):37-41.
1999: Dimitrios Pectasides; Gerasimos Aravantinos; A Visvikis; Charalambos Bakoyiannis; A Halikia; Charalambos Kalofonos; Paris A Kosmidis; Dimosthenis Skarlos; George Fountzilas
Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Oncology 1999;57(1):1-9.
1999: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; A Liaros; Eleni Athanassiou; Nicholas V Dombros; Christos Dervenis; George Basdanis; Orestis G Gamvros; A Souparis; Evangelos Briasoulis; Epaminondas Samantas; Angelos M Kappas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
1999: Dimitrios Bafaloukos; Gerasimos Aravantinos; G Samonis; G Katsifis; Charalambos Bakoyiannis; Dimosthenis Skarlos; Paris A Kosmidis
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group study.
Oncology 1999;56(3):198-201.
1998: George Fountzilas; Costas Nicolaides; Gerasimos Aravantinos; Dimosthenis Skarlos; Paris A Kosmidis; Pavlos Papakostas; George P Stathopoulos; E Kontostolis; Dimitrios Bafaloukos; Nicholas Pavlidis
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: George Fountzilas; Athanassios Meletios Dimopoulos; Christos Papadimitriou; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; A Athanassiades; Costas Nicolaides; A Keramopoulos; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
1998: Costas Nicolaides; George Fountzilas; Nicholas C Zoumbos; Dimosthenis Skarlos; Paris A Kosmidis; Dimitrios Pectasides; Athanasios Karabelis; THEODORE GIANNAKAKIS; Argyris Symeonidis; A Papadopoulos; F Antoniou; Nicholas Pavlidis
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Oncology 1998;55(5):405-15.
1998: E Briasoulis; M Tsokos; G Fountzilas; Dimitrios Bafaloukos; P Kosmidis; Epaminondas Samantas; Dimosthenis Skarlos; Costas Nicolaides; N Pavlidis
Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.
Anticancer research 1998;18(3B):1907-14.
1998: Costas Nicolaides; THEODORE GIANNAKAKIS; Dimosthenis Skarlos; AP Athanassiadis; George Fountzilas; D Damigos; Nicholas Pavlidis
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Journal of experimental & clinical cancer research : CR 1998;17(1):71-5.
1998: Anna Kalogera-Fountzila; Paris A Kosmidis; Christos Bacoyiannis; Angelos Nicolaou; Epaminondas Samantas; Evangelos Briassoulis; Nicholas Pavlidis; Dimosthenis Skarlos; John Daniilidis; George Fountzilas
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer.
Anticancer research 1998;18(1B):587-93.
1998: Dimitrios Bafaloukos; George Fountzilas; Dimosthenis Skarlos; Nicholas Pavlidis; Charalambos Bakoyiannis; N Karvounis; Paris A Kosmidis
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
Oncology 1998;55(1):48-52.
1997: George Fountzilas; A Athanassiades; THEODORE GIANNAKAKIS; Evangelos Briasoulis; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; A Onienaoum; Haralambos Kalofonos; Dimitrios Pectasides; Eleni Andreopoulou; Christina Bamia; Paris A Kosmidis; Nicholas Pavlidis; Dimosthenis Skarlos
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
1997: George Fountzilas; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Evangelos Briassoulis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-28-S19-32.
1997: George Fountzilas; AP Athanassiadis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Briasoulis; Nicholas V Dombros; Ioannis Ioannidis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Nicolas Tsavaris; N Primikirios; Nicolas Mylonakis; G Varouchakis; Theodosios Dosios; Nicholas Pavlidis; Dimosthenis Skarlos; T Tasopoulos; J Dritsas; Paris A Kosmidis
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Anticancer research 1997;17(5B):3799-802.
1997: Paris A Kosmidis; Nicolas Mylonakis; George Fountzilas; Epaminondas Samantas; AP Athanassiadis; Nicholas Pavlidis; Dimosthenis Skarlos
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Seminars in oncology 1997;24(4 Suppl 12):S12-30-S12-33.
1997: George Fountzilas; AP Athanassiadis; Angelos Nikolaou; Anna Kalogera-Fountzila; John Tzitzikas; Epaminondas Samantas; Dimosthenis Skarlos; Nikolaos Zamboglou; John Daniilidis
Accelerated bifractionated radiation with concurrent cisplatin administration in locally advanced head and neck cancer: a feasibility study.
Tumori 1997;83(4):735-9.
1997: Paris A Kosmidis; Nicolas Mylonakis; George Fountzilas; Epaminondas Samantas; A Athanasiadis; Eleni Andreopoulou; Nicholas Pavlidis; Dimosthenis Skarlos
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):697-9.
1997: George Fountzilas; Paris A Kosmidis; V Avramidis; Angelos Nikolaou; Anna Kalogera-Fountzila; P Makrantonakis; Christos Bacoyiannis; Epaminondas Samantas; Dimosthenis Skarlos; John Daniilidis
Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study.
Medical and pediatric oncology 1997;28(6):401-10.
1997: George Fountzilas; Dimosthenis Skarlos; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Angelos Nicolaou; Nicholas V Dombros; Evangelos Briasoulis; M Dinopoulou; George P Stathopoulos; Nicholas Pavlidis; Paris A Kosmidis; John Daniilidis
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1997: Paris A Kosmidis; Christos Bacoyiannis; George Fountzilas; Gerasimos Aravantinos; Nicolas Tsavaris; C Milathianakis; Dimosthenis Skarlos
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):373-8.
1997: Costas Nicolaides; George Klouvas; George Fountzilas; AP Athanassiadis; Dimosthenis Skarlos; Epaminondas Samantas; P Kosmidis; Nicolas Mylonakis; Nicholas Pavlidis
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).
Journal of experimental & clinical cancer research : CR 1997;16(1):91-4.
1997: George Fountzilas; AP Athanassiadis; Epaminondas Samantas; Dimosthenis Skarlos; Anna Kalogera-Fountzila; Angelos Nikolaou; H Bacoyiannis; George P Stathopoulos; Paris A Kosmidis; John Daniilidis
Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
Seminars in oncology 1997;24(1 Suppl 2):S2-65-S2-67.